Johannes Jan Platteeuw

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Johannes Jan Platteeuw: Innovator in Pharmaceutical Dosage Units

Introduction

Johannes Jan Platteeuw is a notable inventor in the field of pharmaceuticals, particularly known for his work on orally disintegrating solid dosage units. His innovative approach focuses on enhancing the delivery of active pharmaceutical ingredients, making medications more accessible and effective for patients.

Latest Patents

Although Johannes Jan Platteeuw currently holds no patents, he has developed significant inventions. One of his latest inventions is an orally disintegrating solid dosage unit containing an estetrol component. This dosage unit weighs between 50-1,000 mg and includes at least 0.1 mg of an estetrol component, which can be estetrol, estetrol esters, or combinations thereof. The formulation consists of 4-95 wt.% of granules, which include 3-80 wt.% of the estetrol component, 20-97 wt.% of C4-C12 sugar alcohol, and 0-45 wt.% of other pharmaceutically acceptable ingredients. This solid dosage unit is particularly suited for sublingual, buccal, or sublabial administration of the estetrol component. Another significant invention is a process for the preparation of estetrol, which involves a silyl enol ether derivative, showcasing his expertise in synthetic processes.

Career Highlights

Throughout his career, Johannes Jan Platteeuw has worked with various companies, including Donesta Bioscience B.V. and Estetra Srl. His contributions to these organizations have been instrumental in advancing pharmaceutical technologies and improving drug formulations.

Collaborations

Johannes has collaborated with notable professionals in the field, including Herman Jan Coelingh Bennink and Franciscus Wilhelmus Damen. These collaborations have enriched his work and contributed to the development of innovative pharmaceutical solutions.

Conclusion

Johannes Jan Platteeuw is a dedicated inventor whose work in pharmaceutical dosage units has the potential to significantly impact patient care. His innovative approaches and collaborations highlight his commitment to advancing the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…